EFSA finds nothing wrong with GM maize
GM 1507 maize has been developed for protection against specific lepidopteran pests such as the European corn borer. It also contains a gene providing tolerance to the herbicide glufosinate.
04/03/05 A European Food Safety Authority Panel has concluded that there is no evidence to indicate that the placing of 1507 maize and derived products on the market is likely to cause adverse effects on human or animal health or the environment. The original application had come in June last year from Pioneer Overseas Corporation/Mycogen Seeds in the Netherlands.
GM 1507 maize has been developed for protection against specific lepidopteran pests such as the European corn borer. It also contains a gene providing tolerance to the herbicide glufosinate. This is the first application reviewed by the EFSA GMO Panel under the GM Food and Feed Regulation. It is also the first time that EFSA’s GMO Panel has published an opinion relating to GM plant cultivation. The Panel has concluded that 1507 maize will not have an adverse effect on human and animal health or the environment in the context of its proposed use. No data have emerged to indicate that 1507 maize is any less safe than its conventional counterpart.
The GM 1507 maize was assessed with reference to its intended use employing the appropriate principles as described in the “Guidance Document of the Scientific Panel on Genetically Modified Organisms for the Risk Assessment of Genetically Modified Plants and Derived Food and Feed” published by EFSA . In addition to the examination of newly introduced DNA and proteins, comparative analyses of agronomic traits and composition were undertaken so that both nutritional quality and safety of the whole food and feed were evaluated. Furthermore a full environmental assessment was undertaken, including an assessment of the post-market monitoring plan.